Venture Capital News Daily
   Your Source for Venture Capital and Private Equity Financings
   Massinvestor/VC News Daily      
   Venture Capital News Daily on RSS Venture Capital News Daily on Facebook Venture Capital News Daily on Twitter
VC Directories Mobile Apps Celebrity VCs VentureTrackr Archive About Us
 
VC-funded Company:


Fractyl Labs
203 Crescent St.
Waltham, MA 02453
Phone: 781-902-8800
http://fractyl.com/

New physiologic lessons highlight the role of intestine hormones in contributing to insulin resistance. Fractyl has developed a device-based endoscopic procedure to directly address this intestinal hormonal impairment using an outpatient therapy. Fractyl is currently engaged in clinical trials designed to demonstrate that its endoscopic procedure can dramatically improve glucose control and potentially reduce the need for additional medications. The company's mission is to set people free from the daily burdens of type 2 diabetes management, empower physicians with a safe and reliable therapeutic treatment option, and lower the tremendous human and financial costs of diabetic complications for patients, hospitals, and payers.

Key Contact
NameTitleE-Mail
Harith RajagopalanCEOharith@fractyl.com


Funding Events
DateAmountTypeInvestors
09/04/14$40,000,000Series C Bessemer Venture Partners
Domain Associates
General Catalyst Partners
11/30/17$44,000,000Series D Bessemer Venture Partners
Deerfield Management Company, L.P.
Domain Associates
Emergent Medical Partners
General Catalyst Partners
Google Ventures
IDO Fund
Mithril Capital Management
True Ventures
 
Massinvestor/VC News Daily
617-620-4606


© 2017 Massinvestor, Inc.